ALKS
Alkermes plc
Latest News for ALKS
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Gilead Sciences (GILD) and Alkermes (ALKS) with bull......
Alkermes ( ($ALKS) ) has issued an announcement. At its annual general meeting on May 20, 2026, Alkermes shareholders approved amendments to the co......
Alkermes plc ($ALKS) announced an update on their ongoing clinical study. The Brilliance NT1 Study 304 is a phase 3 trial run by Alkermes, Inc. to ......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Allogene Therapeutics (ALLO), Evommune, Inc. (EVMN) ......
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Harmony Biosciences Holdings (HRMY), Maravai Lifes......
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Harmony Biosciences Holdings (HRMY), Maravai Lifes......
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Medline (MDLN), Aclaris Therapeutics (ACRS) and Alkermes (ALKS). ......
Alkermes plc ($ALKS) announced an update on their ongoing clinical study. The Brilliance NT2 Study 303 is a phase 3 trial from Alkermes, Inc. that ......
H.C. Wainwright analyst Douglas Tsao reiterated a Hold rating on Alkermes today and set a price target of $43.00. According to TipRanks, Tsao is a ......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alkermes (ALKS) and Tenaya Therapeutics (TNYA) with ......
News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 13 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALKS | $37.35 | +1.5% | 1.12M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |